Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Analysis and Forecast 2025-2031
Description
Summary
According to APO Research, The global Transient Receptor Potential Cation Channel Subfamily V Member 1 market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Transient Receptor Potential Cation Channel Subfamily V Member 1 is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Transient Receptor Potential Cation Channel Subfamily V Member 1 is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Transient Receptor Potential Cation Channel Subfamily V Member 1 is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Transient Receptor Potential Cation Channel Subfamily V Member 1 is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Transient Receptor Potential Cation Channel Subfamily V Member 1 include Amgen Inc, Vitality Biopharma Inc, Toray Industries Inc, Sylentis SAU, Pila Pharma AB, Neurim Pharmaceuticals Ltd, Medifron DBT Co Ltd, Kyowa Hakko Kirin Co Ltd and Grunenthal GmbH, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Transient Receptor Potential Cation Channel Subfamily V Member 1, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Transient Receptor Potential Cation Channel Subfamily V Member 1, also provides the revenue of main regions and countries. Of the upcoming market potential for Transient Receptor Potential Cation Channel Subfamily V Member 1, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Transient Receptor Potential Cation Channel Subfamily V Member 1 revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Transient Receptor Potential Cation Channel Subfamily V Member 1 market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Transient Receptor Potential Cation Channel Subfamily V Member 1 revenue, projected growth trends, production technology, application and end-user industry.
Transient Receptor Potential Cation Channel Subfamily V Member 1 Segment by Company
Amgen Inc
Vitality Biopharma Inc
Toray Industries Inc
Sylentis SAU
Pila Pharma AB
Neurim Pharmaceuticals Ltd
Medifron DBT Co Ltd
Kyowa Hakko Kirin Co Ltd
Grunenthal GmbH
Flex Pharma Inc
DoNatur GmbH
Daewoong Pharmaceutical Co Ltd
Centrexion Therapeutics Corp
BCN Peptides SA
Amorepacific Corp
Transient Receptor Potential Cation Channel Subfamily V Member 1 Segment by Type
DD-04107
CMX-020
CA-016
Others
Transient Receptor Potential Cation Channel Subfamily V Member 1 Segment by Application
Abdominal Pain
Muscle Spasm
Immunology
Pruritus
Ophthalmology
Others
Transient Receptor Potential Cation Channel Subfamily V Member 1 Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transient Receptor Potential Cation Channel Subfamily V Member 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Transient Receptor Potential Cation Channel Subfamily V Member 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transient Receptor Potential Cation Channel Subfamily V Member 1.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Transient Receptor Potential Cation Channel Subfamily V Member 1 in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Transient Receptor Potential Cation Channel Subfamily V Member 1 company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Transient Receptor Potential Cation Channel Subfamily V Member 1 revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
According to APO Research, The global Transient Receptor Potential Cation Channel Subfamily V Member 1 market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Transient Receptor Potential Cation Channel Subfamily V Member 1 is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Transient Receptor Potential Cation Channel Subfamily V Member 1 is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Transient Receptor Potential Cation Channel Subfamily V Member 1 is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Transient Receptor Potential Cation Channel Subfamily V Member 1 is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Transient Receptor Potential Cation Channel Subfamily V Member 1 include Amgen Inc, Vitality Biopharma Inc, Toray Industries Inc, Sylentis SAU, Pila Pharma AB, Neurim Pharmaceuticals Ltd, Medifron DBT Co Ltd, Kyowa Hakko Kirin Co Ltd and Grunenthal GmbH, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Transient Receptor Potential Cation Channel Subfamily V Member 1, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Transient Receptor Potential Cation Channel Subfamily V Member 1, also provides the revenue of main regions and countries. Of the upcoming market potential for Transient Receptor Potential Cation Channel Subfamily V Member 1, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Transient Receptor Potential Cation Channel Subfamily V Member 1 revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Transient Receptor Potential Cation Channel Subfamily V Member 1 market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Transient Receptor Potential Cation Channel Subfamily V Member 1 revenue, projected growth trends, production technology, application and end-user industry.
Transient Receptor Potential Cation Channel Subfamily V Member 1 Segment by Company
Amgen Inc
Vitality Biopharma Inc
Toray Industries Inc
Sylentis SAU
Pila Pharma AB
Neurim Pharmaceuticals Ltd
Medifron DBT Co Ltd
Kyowa Hakko Kirin Co Ltd
Grunenthal GmbH
Flex Pharma Inc
DoNatur GmbH
Daewoong Pharmaceutical Co Ltd
Centrexion Therapeutics Corp
BCN Peptides SA
Amorepacific Corp
Transient Receptor Potential Cation Channel Subfamily V Member 1 Segment by Type
DD-04107
CMX-020
CA-016
Others
Transient Receptor Potential Cation Channel Subfamily V Member 1 Segment by Application
Abdominal Pain
Muscle Spasm
Immunology
Pruritus
Ophthalmology
Others
Transient Receptor Potential Cation Channel Subfamily V Member 1 Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transient Receptor Potential Cation Channel Subfamily V Member 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Transient Receptor Potential Cation Channel Subfamily V Member 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transient Receptor Potential Cation Channel Subfamily V Member 1.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Transient Receptor Potential Cation Channel Subfamily V Member 1 in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Transient Receptor Potential Cation Channel Subfamily V Member 1 company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Transient Receptor Potential Cation Channel Subfamily V Member 1 revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
194 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market by Type
- 1.2.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type, 2020 VS 2024 VS 2031
- 1.2.2 DD-04107
- 1.2.3 CMX-020
- 1.2.4 CA-016
- 1.2.5 Others
- 1.3 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market by Application
- 1.3.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application, 2020 VS 2024 VS 2031
- 1.3.2 Abdominal Pain
- 1.3.3 Muscle Spasm
- 1.3.4 Immunology
- 1.3.5 Pruritus
- 1.3.6 Ophthalmology
- 1.3.7 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
- 2 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Dynamics
- 2.1 Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Trends
- 2.2 Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Drivers
- 2.3 Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Opportunities and Challenges
- 2.4 Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Restraints
- 3 Global Growth Perspective
- 3.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Perspective (2020-2031)
- 3.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Growth Trends by Region
- 3.2.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region: 2020 VS 2024 VS 2031
- 3.2.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region (2020-2025)
- 3.2.3 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region (2026-2031)
- 4 Competitive Landscape by Players
- 4.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Players
- 4.1.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Players (2020-2025)
- 4.1.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Players (2020-2025)
- 4.1.3 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Players Revenue Share Top 10 and Top 5 in 2024
- 4.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Key Players Ranking, 2023 VS 2024 VS 2025
- 4.3 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Key Players Headquarters & Area Served
- 4.4 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Players, Product Type & Application
- 4.5 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market CR5 and HHI
- 4.6.3 2024 Transient Receptor Potential Cation Channel Subfamily V Member 1 Tier 1, Tier 2, and Tier 3
- 5 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type
- 5.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2020 VS 2024 VS 2031)
- 5.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2020-2031)
- 5.3 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Type (2020-2031)
- 6 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application
- 6.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2020 VS 2024 VS 2031)
- 6.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2020-2031)
- 6.3 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Application (2020-2031)
- 7 Company Profiles
- 7.1 Amgen Inc
- 7.1.1 Amgen Inc Comapny Information
- 7.1.2 Amgen Inc Business Overview
- 7.1.3 Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (2020-2025)
- 7.1.4 Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
- 7.1.5 Amgen Inc Recent Developments
- 7.2 Vitality Biopharma Inc
- 7.2.1 Vitality Biopharma Inc Comapny Information
- 7.2.2 Vitality Biopharma Inc Business Overview
- 7.2.3 Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (2020-2025)
- 7.2.4 Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
- 7.2.5 Vitality Biopharma Inc Recent Developments
- 7.3 Toray Industries Inc
- 7.3.1 Toray Industries Inc Comapny Information
- 7.3.2 Toray Industries Inc Business Overview
- 7.3.3 Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (2020-2025)
- 7.3.4 Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
- 7.3.5 Toray Industries Inc Recent Developments
- 7.4 Sylentis SAU
- 7.4.1 Sylentis SAU Comapny Information
- 7.4.2 Sylentis SAU Business Overview
- 7.4.3 Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (2020-2025)
- 7.4.4 Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
- 7.4.5 Sylentis SAU Recent Developments
- 7.5 Pila Pharma AB
- 7.5.1 Pila Pharma AB Comapny Information
- 7.5.2 Pila Pharma AB Business Overview
- 7.5.3 Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (2020-2025)
- 7.5.4 Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
- 7.5.5 Pila Pharma AB Recent Developments
- 7.6 Neurim Pharmaceuticals Ltd
- 7.6.1 Neurim Pharmaceuticals Ltd Comapny Information
- 7.6.2 Neurim Pharmaceuticals Ltd Business Overview
- 7.6.3 Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (2020-2025)
- 7.6.4 Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
- 7.6.5 Neurim Pharmaceuticals Ltd Recent Developments
- 7.7 Medifron DBT Co Ltd
- 7.7.1 Medifron DBT Co Ltd Comapny Information
- 7.7.2 Medifron DBT Co Ltd Business Overview
- 7.7.3 Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (2020-2025)
- 7.7.4 Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
- 7.7.5 Medifron DBT Co Ltd Recent Developments
- 7.8 Kyowa Hakko Kirin Co Ltd
- 7.8.1 Kyowa Hakko Kirin Co Ltd Comapny Information
- 7.8.2 Kyowa Hakko Kirin Co Ltd Business Overview
- 7.8.3 Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (2020-2025)
- 7.8.4 Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
- 7.8.5 Kyowa Hakko Kirin Co Ltd Recent Developments
- 7.9 Grunenthal GmbH
- 7.9.1 Grunenthal GmbH Comapny Information
- 7.9.2 Grunenthal GmbH Business Overview
- 7.9.3 Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (2020-2025)
- 7.9.4 Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
- 7.9.5 Grunenthal GmbH Recent Developments
- 7.10 Flex Pharma Inc
- 7.10.1 Flex Pharma Inc Comapny Information
- 7.10.2 Flex Pharma Inc Business Overview
- 7.10.3 Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (2020-2025)
- 7.10.4 Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
- 7.10.5 Flex Pharma Inc Recent Developments
- 7.11 DoNatur GmbH
- 7.11.1 DoNatur GmbH Comapny Information
- 7.11.2 DoNatur GmbH Business Overview
- 7.11.3 DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (2020-2025)
- 7.11.4 DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
- 7.11.5 DoNatur GmbH Recent Developments
- 7.12 Daewoong Pharmaceutical Co Ltd
- 7.12.1 Daewoong Pharmaceutical Co Ltd Comapny Information
- 7.12.2 Daewoong Pharmaceutical Co Ltd Business Overview
- 7.12.3 Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (2020-2025)
- 7.12.4 Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
- 7.12.5 Daewoong Pharmaceutical Co Ltd Recent Developments
- 7.13 Centrexion Therapeutics Corp
- 7.13.1 Centrexion Therapeutics Corp Comapny Information
- 7.13.2 Centrexion Therapeutics Corp Business Overview
- 7.13.3 Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (2020-2025)
- 7.13.4 Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
- 7.13.5 Centrexion Therapeutics Corp Recent Developments
- 7.14 BCN Peptides SA
- 7.14.1 BCN Peptides SA Comapny Information
- 7.14.2 BCN Peptides SA Business Overview
- 7.14.3 BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (2020-2025)
- 7.14.4 BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
- 7.14.5 BCN Peptides SA Recent Developments
- 7.15 Amorepacific Corp
- 7.15.1 Amorepacific Corp Comapny Information
- 7.15.2 Amorepacific Corp Business Overview
- 7.15.3 Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (2020-2025)
- 7.15.4 Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
- 7.15.5 Amorepacific Corp Recent Developments
- 8 North America
- 8.1 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (2020-2031)
- 8.2 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2020-2031)
- 8.2.1 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2020-2025)
- 8.2.2 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2026-2031)
- 8.3 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Share by Type (2020-2031)
- 8.4 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2020-2031)
- 8.4.1 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2020-2025)
- 8.4.2 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2026-2031)
- 8.5 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Share by Application (2020-2031)
- 8.6 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country
- 8.6.1 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2020 VS 2024 VS 2031)
- 8.6.2 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2020-2025)
- 8.6.3 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2026-2031)
- 8.6.4 United States
- 8.6.5 Canada
- 9 Europe
- 9.1 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (2020-2031)
- 9.2 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2020-2031)
- 9.2.1 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2020-2025)
- 9.2.2 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2026-2031)
- 9.3 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Share by Type (2020-2031)
- 9.4 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2020-2031)
- 9.4.1 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2020-2025)
- 9.4.2 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2026-2031)
- 9.5 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Share by Application (2020-2031)
- 9.6 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country
- 9.6.1 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2020 VS 2024 VS 2031)
- 9.6.2 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2020-2025)
- 9.6.3 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2026-2031)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Netherlands
- 10 China
- 10.1 China Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (2020-2031)
- 10.2 China Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2020-2031)
- 10.2.1 China Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2020-2025)
- 10.2.2 China Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2026-2031)
- 10.3 China Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Share by Type (2020-2031)
- 10.4 China Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2020-2031)
- 10.4.1 China Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2020-2025)
- 10.4.2 China Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2026-2031)
- 10.5 China Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Share by Application (2020-2031)
- 11 Asia (Excluding China)
- 11.1 Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (2020-2031)
- 11.2 Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2020-2031)
- 11.2.1 Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2020-2025)
- 11.2.2 Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2026-2031)
- 11.3 Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Share by Type (2020-2031)
- 11.4 Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2020-2031)
- 11.4.1 Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2020-2025)
- 11.4.2 Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2026-2031)
- 11.5 Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Share by Application (2020-2031)
- 11.6 Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country
- 11.6.1 Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2020 VS 2024 VS 2031)
- 11.6.2 Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2020-2025)
- 11.6.3 Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2026-2031)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
- 12 South America, Middle East and Africa
- 12.1 SAMEA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (2020-2031)
- 12.2 SAMEA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2020-2031)
- 12.2.1 SAMEA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2020-2025)
- 12.2.2 SAMEA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2026-2031)
- 12.3 SAMEA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Share by Type (2020-2031)
- 12.4 SAMEA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2020-2031)
- 12.4.1 SAMEA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2020-2025)
- 12.4.2 SAMEA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2026-2031)
- 12.5 SAMEA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Share by Application (2020-2031)
- 12.6 SAMEA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country
- 12.6.1 SAMEA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2020 VS 2024 VS 2031)
- 12.6.2 SAMEA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2020-2025)
- 12.6.3 SAMEA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2026-2031)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
- 13 Concluding Insights
- 14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.



